This has been hypothesized as ORAI1 hypo-glycosylation has been linked to the development of tubular aggregate myopathy and in limb–girdle CMS patients harboring mutation to DPAGT1 [85]. This evidence concerns the gene ORAI1 and congenital myasthenic syndrome.